Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Costs And Effectiveness Of Prostate Cancer Screening In Elderly Men PDF full book. Access full book title Costs And Effectiveness Of Prostate Cancer Screening In Elderly Men.
| Author | : DIANE Publishing Company |
| Publisher | : DIANE Publishing |
| Total Pages | : 141 |
| Release | : 1998 |
| Genre | : |
| ISBN | : 0788132903 |
| Author | : |
| Publisher | : DIANE Publishing |
| Total Pages | : 134 |
| Release | : |
| Genre | : |
| ISBN | : 1428920099 |
| Author | : United States. Congress. Office of Technology Assessment |
| Publisher | : U.S. Government Printing Office |
| Total Pages | : 162 |
| Release | : 1995 |
| Genre | : Health & Fitness |
| ISBN | : |
| Author | : |
| Publisher | : |
| Total Pages | : 130 |
| Release | : 1995 |
| Genre | : |
| ISBN | : |
In recent years, the prostate cancer diagnosis rate has increased dramatically, with a slower increase in age-specific mortality. At least in part, the increasing incidence undoubtedly reflects more aggressive efforts at early detection of prostate cancer, particularly through the use of a new blood test, prostate-specific antigen (PSA). This background paper examines the implications of a potential Medicare benefit to cover prostate cancer screening using a combination of the PSA and digital rectal examination (DRE), a time-honored test performed in the physician's office. OTA concludes that the evidence of benefit for prostate cancer screening is substantially weaker than for preventive services already covered by Medicare. Because the scientific knowledge is limited, but the consequences of prostate cancer and its treatment are serious, an informed patient and his physician could equally well decide to receive screening or forgo it. Medicare reimbursement could be one means of insuring that out-of-pocket expenses not impede well-informed decision-making between physician and patient about whether to receive screening.
| Author | : Congress of the United States. Office of Technology Assessment, OTA |
| Publisher | : |
| Total Pages | : 130 |
| Release | : 1995 |
| Genre | : |
| ISBN | : |
In recent years, the prostate cancer diagnosis rate has increased dramatically, with a slower increase in age-specific mortality. At least in part, the increasing incidence undoubtedly reflects more aggressive efforts at early detection of prostate cancer, particularly through the use of a new blood test, prostate-specific antigen (PSA). This background paper examines the implications of a potential Medicare benefit to cover prostate cancer screening using a combination of the PSA and digital rectal examination (DRE), a time-honored test performed in the physician's office. OTA concludes that the evidence of benefit for prostate cancer screening is substantially weaker than for preventive services already covered by Medicare. Because the scientific knowledge is limited, but the consequences of prostate cancer and its treatment are serious, an informed patient and his physician could equally well decide to receive screening or forgo it. Medicare reimbursement could be one means of insuring that out-of-pocket expenses not impede well-informed decision-making between physician and patient about whether to receive screening.
| Author | : Gordon Press Publishers |
| Publisher | : |
| Total Pages | : |
| Release | : 1997-06 |
| Genre | : |
| ISBN | : 9780849060762 |
Discusses the possibility of having Medicare cover prostate cancer (PC) screening. Weighs the benefits and risks of screening and considers the possibility that reimbursement by Medicare could help patients make better decisions which would not be based on money alone. Provides information about PC: the basic biology of PC, risk factors for the disease, mortality rates, etc. Presents the technologies available for early detection along with treatment possibilities. Provides studies of: digital rectal exams, prostate-specific antigens, and transrectal ultrasound. Illustrated.
| Author | : |
| Publisher | : |
| Total Pages | : 112 |
| Release | : 1992 |
| Genre | : Automobiles |
| ISBN | : |
| Author | : Bill Fell |
| Publisher | : |
| Total Pages | : 122 |
| Release | : 2006 |
| Genre | : Medical screening |
| ISBN | : |
Prostate cancer is a common form of cancer in men. In fact, prostate cancer has the highest incidence of any cancer in men. Prostate cancer is not only common, it carries a significant financial burden. The cost of prostate cancer is 11.3% of all cancer expenditures. If after a DRE the prostate is enlarged, or if the PSA is elevated, then a biopsy of the prostate would be recommended. Under the best of circumstances, cancer diagnoses will be missed and many will undergo unnecessary biopsy, etc. The focus of this paper was the cost-utility of screening with the PSA test. The cost differences between screening and not screening was compared. A Markov analysis and a Monte Carlo simulation were utilized to provide a basis for conclusion. The primary finding is that the costs associated with screening are much higher than those of not screening. Additional findings are that the specificity of the PSA test, the first year treatment costs, and the utility/outcomes of screening have an impact on the cost-utility of screening. The conclusion, however, is that the improvements in these factors would have to be significant to impact the case for screening. Until longitudinal studies are completed, it is not cost-effective to screen for prostate cancer.
| Author | : Richard J. Ablin |
| Publisher | : Macmillan |
| Total Pages | : 274 |
| Release | : 2014-03-04 |
| Genre | : Health & Fitness |
| ISBN | : 1137278749 |
Reveals how fear-based and inaccurate testing is resulting in unnecessary high-risk surgeries, arguing that the PSA test was never intended for prostate cancer screening.
| Author | : Justo Méndez |
| Publisher | : |
| Total Pages | : 120 |
| Release | : 2006 |
| Genre | : Medical screening |
| ISBN | : |
